Salem Capital Management Inc Johnson & Johnson Transaction History

Salem Capital Management Inc

$126 Million
Q3 2022

A detailed history of Salem Capital Management Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Salem Capital Management Inc holds 20,826 shares of JNJ stock, worth $3.42 Million. This represents 2.69% of its overall portfolio holdings.

Number of Shares

20,826

Previous 20,826 -0.0%

Holding current value

$3.42 Million

Previous $3.7 Million 7.98%

% of portfolio

2.69%

Previous 2.7%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$168.19 - $186.01 $499,692 - $552,635	-2,971 Reduced 12.48%	20,826 $3.7 Million
Q1 2022 Apr 07, 2022	SELL	$158.14 - $179.59 $63,255 - $71,836	-400 Reduced 1.65%	23,797 $4.22 Million
Q4 2021 Jan 18, 2022	SELL	$155.93 - $173.01 $13,098 - $14,532	-84 Reduced 0.35%	24,197 $4.14 Million
Q3 2021 Oct 12, 2021	SELL	$161.5 - $179.47 $32,300 - $35,894	-200 Reduced 0.82%	24,281 $3.92 Million
Q2 2021 Jul 13, 2021	SELL	$159.48 - $171.07 $127,743 - $137,027	-801 Reduced 3.17%	24,481 $4.03 Million
Q1 2021 Apr 15, 2021	SELL	$153.07 - $170.48 $61,228 - $68,192	-400 Reduced 1.56%	25,282 $4.16 Million
Q4 2020 Jan 12, 2021	SELL	$137.11 - $157.38 $53,198 - $61,063	-388 Reduced 1.49%	25,682 $4.04 Million
Q3 2020 Oct 13, 2020	SELL	$140.38 - $153.83 $272,477 - $298,584	-1,941 Reduced 6.93%	26,070 $3.88 Million
Q2 2020 Jul 20, 2020	SELL	$128.81 - $155.51 $3,864 - $4,665	-30 Reduced 0.11%	28,011 $3.94 Million
Q1 2020 Apr 14, 2020	SELL	$111.14 - $153.99 $388,990 - $538,965	-3,500 Reduced 11.1%	28,041 $3.68 Million
Q4 2019 Jan 09, 2020	SELL	$127.5 - $146.44 $703,162 - $807,616	-5,515 Reduced 14.88%	31,541 $4.6 Million
Q3 2019 Oct 07, 2019	SELL	$126.95 - $142.14 $2.02 Million - $2.26 Million	-15,890 Reduced 30.01%	37,056 $4.79 Million
Q2 2019 Jul 09, 2019	SELL	$131.15 - $144.24 $642,635 - $706,776	-4,900 Reduced 8.47%	52,946 $7.37 Million
Q1 2019 Apr 15, 2019	SELL	$125.72 - $139.79 $57,202 - $63,604	-455 Reduced 0.78%	57,846 $8.09 Million
Q4 2018 Jan 08, 2019	SELL	$122.84 - $147.84 $34,395 - $41,395	-280 Reduced 0.48%	58,301 $7.52 Million
Q3 2018 Oct 09, 2018	BUY	$121.58 - $142.88 $3,161 - $3,714	26 Added 0.04%	58,581 $8.09 Million
Q2 2018 Jul 09, 2018	SELL	$119.4 - $131.76 $54,924 - $60,609	-460 Reduced 0.78%	58,555 $7.11 Million
Q1 2018 Apr 09, 2018	SELL	$125.1 - $148.14 $87,570 - $103,697	-700 Reduced 1.17%	59,015 $7.56 Million
Q4 2017 Jan 16, 2018	SELL	$131.22 - $143.62 $718,429 - $786,319	-5,475 Reduced 8.4%	59,715 $8.34 Million
Q3 2017 Oct 10, 2017	BUY	$129.47 - $135.38 $8.44 Million - $8.83 Million	65,190	65,190 $8.48 Million

Others Institutions Holding JNJ

# of Institutions

4,157

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $430B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Capital Management Inc with notifications on news.

Account

Salem Capital Management Inc Johnson & Johnson Transaction History